Male Urogenital Diseases: Clinical Trials

28,404 trials for Male Urogenital Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14532 completed, 4084 unknown, 3489 recruiting, 2217 terminated. 8620 Not applicable, 5761 Phase 2, 3516 Phase 1, 2733 Phase 3, 1916 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8620Completed 4218, Unknown 1457, Recruiting 1156, Not yet recruiting 516, Terminated 482, Active not recruiting 395, Withdrawn 286, Enrolling by invitation 83, Suspended 27
Phase 25761Completed 2904, Terminated 789, Recruiting 696, Unknown 548, Active not recruiting 353, Withdrawn 237, Not yet recruiting 200, Suspended 20, Enrolling by invitation 14
Phase 13516Completed 1953, Recruiting 441, Terminated 404, Unknown 249, Active not recruiting 216, Withdrawn 120, Not yet recruiting 107, Suspended 16, Enrolling by invitation 10
Phase 32733Completed 1534, Unknown 292, Terminated 286, Recruiting 256, Active not recruiting 180, Withdrawn 100, Not yet recruiting 73, Enrolling by invitation 6, Suspended 6
Phase 41916Completed 1048, Unknown 348, Terminated 167, Recruiting 140, Withdrawn 85, Not yet recruiting 68, Active not recruiting 42, Enrolling by invitation 9, Suspended 9
Early Phase 1331Completed 131, Unknown 54, Recruiting 51, Not yet recruiting 25, Terminated 22, Withdrawn 21, Active not recruiting 19, Enrolling by invitation 6, Suspended 2

Follow Male Urogenital Diseases: new trials by email Literature Review of Male Urogenital Diseases trials Research Report on Male Urogenital Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
serum creatinine assay - Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Contrast concentration in urine - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-11-012023-10-19
Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
serum creatinine assay - Renal Insufficiency, Acute Kidney Injury
WithdrawnMaastricht University Medical Center2097-05-012023-10-19
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
Naloxégol oxalate, Placebo oral tablet - Bladder Cancer, Cystostomy; Complications
Phase 2WithdrawnInstitut Paoli-Calmettes2032-01-012026-10-14
PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
(a) Training and (b) Supported risk assessment - Prostate Cancer, Risk Assessment
Not applicableNot yet recruitingAhmadu Bello University892029-03-012026-07-29
Antibiotics for Kidney Transplant Recipients
Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care - Kidney Transplant, Urinary Tract Infection(UTI)
Phase 4Not yet recruitingUniversity of California, San Francisco502028-10-012026-09-11
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
AI Uro-Cam - Bladder Cancer
Not applicableNot yet recruitingChinese University of Hong Kong602028-07-312026-07-22
MRI Technical Development and Applications in Kidney Disease
Chronic Kidney Diseases, Kidney Transplantation
Not yet recruitingUniversity of Minnesota1802028-06-302026-04-13
Device for Bladder Control for Men With SCI
Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder
Phase 1 / Phase 2Not yet recruitingVA Office of Research and Development122028-06-012026-06-25
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy
177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended phase 2 regime - Cancer, Prostate Cancer
Phase 1 / Phase 2Not yet recruitingCHU de Quebec-Universite Laval5002028-03-012025-03-30
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
NM8074 - IgA Nephropathy
Phase 2Not yet recruitingNovelMed Therapeutics102028-02-012026-04-13
School-Based Bladder Health Intervention
Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms
Not applicableWithdrawnStanford University2028-01-012026-05-07
Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury
PRECISE-AKI Clinical Decision Support Tool - Acute Kidney Injury (AKI)
Not applicableNot yet recruitingVA Office of Research and Development602028-01-012025-10-16
CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)
CB-010 - Systemic Lupus Erythematosus, Lupus
Phase 1WithdrawnCaribou Biosciences, Inc.2027-12-012025-09-19
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome
Phase 2Not yet recruitingNovelMed Therapeutics122027-11-012026-04-13
Veteran Centered Meal Intervention in Chronic Kidney Disease
Medically tailored meals (MTMs) - Chronic Kidney Disease
Not applicableNot yet recruitingVA Office of Research and Development1002027-10-012026-09-03
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Amino Acid Therapy Evaluating the Incidence of New-Onset AKI
Amino Acid infusion, Lactated Ringer Solution - Acute Kidney Injury
Phase 2Not yet recruitingChildren's Hospital Medical Center, Cincinnati2702027-10-012026-10-21
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16

Showing 20 of 28404. Sign in to see all of them.

Narrower conditions

Prostatic Neoplasms (6443)  ·  Renal Insufficiency, Chronic (3071)  ·  Kidney Failure, Chronic (1997)  ·  Carcinoma, Renal Cell (1956)  ·  Urinary Bladder Neoplasms (1723)  ·  Acute Kidney Injury (1614)  ·  Renal Insufficiency (1370)  ·  Kidney Diseases (965)  ·  Kidney Neoplasms (956)  ·  Urinary Incontinence (934)  ·  Neoplasms (863)  ·  Breast Neoplasms (829)  ·  Prostatic Hyperplasia (805)  ·  Urinary Bladder, Overactive (801)  ·  Urinary Tract Infections (719)

Broader conditions

Urogenital Diseases (28365)  ·  Female Urogenital Diseases and Pregnancy Complications (20448)  ·  Female Urogenital Diseases (20432)  ·  Urologic Diseases (18961)  ·  Kidney Diseases (12284)  ·  Pathological Conditions, Signs and Symptoms (11123)  ·  Neoplasms by Site (10947)  ·  Urogenital Neoplasms (10744)  ·  Neoplasms (10436)  ·  Genital Diseases (9760)  ·  Genital Diseases, Male (9172)  ·  Prostatic Diseases (7234)  ·  Pathologic Processes (7071)  ·  Genital Neoplasms, Male (6794)

Interventions

Docetaxel (360)  ·  Prednisone (347)  ·  pembrolizumab (272)  ·  Magnetic Resonance Spectroscopy (268)  ·  Radiotherapy (249)  ·  Gemcitabine (232)  ·  enzalutamide (222)  ·  Nivolumab (221)  ·  Blood Specimen Collection (212)  ·  Leuprolide (193)  ·  Cyclophosphamide (191)  ·  Abiraterone Acetate (185)  ·  Standard of Care (181)  ·  Sunitinib (179)  ·  Cisplatin (175)

Sponsors

National Cancer Institute (NCI) (445)  ·  Assiut University (263)  ·  Memorial Sloan Kettering Cancer Center (234)  ·  M.D. Anderson Cancer Center (232)  ·  Bayer (227)  ·  Mayo Clinic (221)  ·  Pfizer (216)  ·  AstraZeneca (197)  ·  Novartis Pharmaceuticals (192)  ·  Assistance Publique - Hôpitaux de Paris (164)  ·  GlaxoSmithKline (155)  ·  University Health Network, Toronto (154)  ·  University of California, San Francisco (146)  ·  Eli Lilly and Company (134)  ·  National Taiwan University Hospital (125)

Countries

United States (11095)  ·  France (2187)  ·  China (2180)  ·  Canada (2072)  ·  United Kingdom (1652)  ·  Germany (1490)  ·  Italy (1474)  ·  Spain (1366)  ·  South Korea (1015)  ·  Turkey (Türkiye) (998)  ·  Netherlands (935)  ·  Belgium (867)  ·  Australia (844)  ·  Egypt (829)  ·  Denmark (785)

Results publications

PMID 40576086, PMID 39356039, PMID 36005278, PMID 37160401, PMID 39704322, PMID 38299639, PMID 37146227, PMID 35224730, PMID 36791280, PMID 32734597, PMID 35018639, PMID 37916745, PMID 39513526, PMID 36416787, PMID 37888839, PMID 34778952, PMID 38770818, PMID 34519356, PMID 33107592, PMID 34184246, PMID 34350976, PMID 37068952, PMID 37811598, PMID 37947276, PMID 38682786, PMID 33314078, PMID 35224732, PMID 38018702, PMID 31401903, PMID 32390133, PMID 33586138, PMID 37870148, PMID 38189593, PMID 39963952, PMID 27238653, PMID 28410911, PMID 33783815, PMID 37651553, PMID 38724717, PMID 39878152, PMID 33283264, PMID 34164803, PMID 36472416, PMID 33782940, PMID 37528520, PMID 39607014, PMID 40337980, PMID 40465397, PMID 12559262, PMID 19941278

NIH funding

2023 (162), 2016 (100), 2017 (94), 2019 (81), 2025 (76), 2018 (74), 2014 (71), 2015 (63), 2008 (50), 2009 (48), P30CA033572 (44), P30CA014089 (37), P30CA043703 (32), U10CA031946 (32), P30CA016672 (30)